Recorded Presentations from the NCCN 2016 Congress Webinar Series: Lung Cancer

This series is designed to educate healthcare professionals on current and emerging scientific data so that they can make evidence-based decisions about screening and treatment for patients with non-small cell lung cancer (NSCLC). The goal of this series is to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists, and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practices and healthcare settings for patients with NSCLC.

Target Audience

This educational program is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with non-small cell lung cancer.

Additional information
Supporters: 

This activity is supported by educational grants from Ariad, AstraZeneca, Ethicon, Foundation Medicine, Genentech, Lilly, Novartis Pharmaceuticals Corporation, and Pfizer. This activity is supported by independent education grants from Abbvie and Merck.

Course summary
Course opens: 
07/29/2016
Course expires: 
07/29/2017
Cost:
$0.00

These activities are approved for AMA PRA Category 1 Credit(s)™ and are also certified for nurses and pharmacists. Complete accreditation details are provided at the beginning of the individual activities.

Available Credit

Accreditation Period

Course opens: 
07/29/2016
Course expires: 
07/29/2017
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.